SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001385508-22-000130
Filing Date
2022-11-14
Accepted
2022-11-14 16:06:19
Documents
16
Period of Report
2022-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opnt-20221113.htm   iXBRL 8-K 39605
2 EX-99.1 opnt_3q22financialresultsx.htm EX-99.1 24370
7 image_0.jpg GRAPHIC 114749
8 image_1.jpg GRAPHIC 124147
  Complete submission text file 0001385508-22-000130.txt   577127

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opnt-20221113.xsd EX-101.SCH 2150
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opnt-20221113_def.xml EX-101.DEF 15433
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opnt-20221113_lab.xml EX-101.LAB 29833
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opnt-20221113_pre.xml EX-101.PRE 16094
10 EXTRACTED XBRL INSTANCE DOCUMENT opnt-20221113_htm.xml XML 14572
Mailing Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 464744124 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 221385126
SIC: 2834 Pharmaceutical Preparations